Pfizer Vaccine - Is It Back To Normal?

The experimental vaccine shows that in 90% of tested cases, it prevents COVID-19 is made public by Pfizer together with BioNTech. Markets react to today's revelations with optimism, but does this solve the problems of the global economy?

Pfizer stock chart, H1 interval. Source: xNUMX XTB.

Pfizer Vaccine - Markets Triumph

We invite you to a special webinar with the Chief Economist of XTB Dr. Przemysław Kwiecień, where you will learn:

• What do we know about the new COVID-19 vaccine?
• What is the importance of inventing a vaccine for the financial markets in the long term?
• Which markets will be won and which will be lost in the new reality?
• How have individual markets responded to the news about the new vaccine?

WATCH ON-LINE

In addition, due to the very dynamic situation in the world, additional ones will be made available video reports on the impact of the coronavirus on the global economy, market analysis precious metals.

About the host

Dr Przemysław Kwiecień - Chief economist X-Trade Brokers. Doctor of Economics at the University of Warsaw, graduate of the University of Warsaw and London Metropolitan University (MSc). Holder of the prestigious CFA certificate. He has been working for XTB since 2007, previously he gained experience as an advisor to the Minister of Finance, Mirosław Gronicki, and an economist at Bank Millennium. At XTB, he manages the Analysis Department.

CFDs are complex instruments and involve a high risk of a quick loss of cash due to leverage. 76% of retail investor accounts record monetary losses as a result of trading CFDs with this CFD provider. Consider whether you understand how CFDs work and whether you can afford the high risk of losing your money.